Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $492.88 million. The enterprise value is $425.85 million.
Important Dates
The last earnings date was Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 26.71 million shares outstanding. The number of shares has increased by 131.04% in one year.
| Current Share Class | 26.71M |
| Shares Outstanding | 26.71M |
| Shares Change (YoY) | +131.04% |
| Shares Change (QoQ) | +10.28% |
| Owned by Insiders (%) | 2.54% |
| Owned by Institutions (%) | 87.09% |
| Float | 20.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8,607.45 |
| Forward PS | n/a |
| PB Ratio | 6.86 |
| P/TBV Ratio | 8.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7,217.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.66
| Current Ratio | 7.66 |
| Quick Ratio | 7.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -88.76% and return on invested capital (ROIC) is -51.61%.
| Return on Equity (ROE) | -88.76% |
| Return on Assets (ROA) | -41.50% |
| Return on Invested Capital (ROIC) | -51.61% |
| Return on Capital Employed (ROCE) | -89.66% |
| Weighted Average Cost of Capital (WACC) | 8.62% |
| Revenue Per Employee | $1,788 |
| Profits Per Employee | -$2.57M |
| Employee Count | 33 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $169,000 in taxes.
| Income Tax | 169,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +413.61% in the last 52 weeks. The beta is 0.79, so AVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +413.61% |
| 50-Day Moving Average | 15.69 |
| 200-Day Moving Average | 14.89 |
| Relative Strength Index (RSI) | 56.26 |
| Average Volume (20 Days) | 2,500,826 |
Short Selling Information
The latest short interest is 5.73 million, so 21.46% of the outstanding shares have been sold short.
| Short Interest | 5.73M |
| Short Previous Month | 5.24M |
| Short % of Shares Out | 21.46% |
| Short % of Float | 27.81% |
| Short Ratio (days to cover) | 7.25 |
Income Statement
In the last 12 months, AVTX had revenue of $59,000 and -$84.74 million in losses. Loss per share was -$5.36.
| Revenue | 59,000 |
| Gross Profit | -35.29M |
| Operating Income | -79.16M |
| Pretax Income | -84.57M |
| Net Income | -84.74M |
| EBITDA | -78.93M |
| EBIT | -79.16M |
| Loss Per Share | -$5.36 |
Full Income StatementBalance Sheet
The company has $81.99 million in cash and n/a in debt, with a net cash position of $81.99 million or $3.07 per share.
| Cash & Cash Equivalents | 81.99M |
| Total Debt | n/a |
| Net Cash | 81.99M |
| Net Cash Per Share | $3.07 |
| Equity (Book Value) | 68.32M |
| Book Value Per Share | 2.77 |
| Working Capital | 77.23M |
Full Balance SheetCash Flow
| Operating Cash Flow | -59.69M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 226,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -59.69M |
| FCF Per Share | -$2.23 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -134,164.41% |
| Pretax Margin | -143,340.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -131.04% |
| Shareholder Yield | -131.04% |
| Earnings Yield | -16.69% |
| FCF Yield | -11.75% |
Analyst Forecast
The average price target for AVTX is $45.20, which is 144.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $45.20 |
| Price Target Difference | 144.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 209.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
